Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Schizophrenia Bulletin
|
May 8, 2007
A UK audit of screening for the metabolic side effects of antipsychotics in community patients
Thomas R E Barnes, Carol Paton, Mary-Rose Cavanagh, et al.
Manual Therapy
|
June 26, 2012
Low back pain: an assessment using positional MRI and MDT
Karen Hedberg, Lyndsay A Alexander, Kay Cooper, et al.
Advances in Therapy
|
February 9, 2020
An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
Daniel Viriato, Natalie Bennett, Raisa Sidhu, et al.
Advances in Therapy
|
September 24, 2024
A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French Registry
Markqayne Ray, Jean-Gabriel Castaigne, Alexandra Zang, et al.
Swiss Medical Weekly
|
November 30, 2017
Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction
Zanfina Ademi, Alena M Pfeil, Elizabeth Hancock, et al.
Addiction (Abingdon, England)
|
October 22, 2019
Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation
Elizabeth Hancock, Zoe Ward, Rachel Ayres, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
March 3, 2016
Patient experience of negative effects of psychological treatment: results of a national survey†
Mike J Crawford, Lavanya Thana, Lorna Farquharson, et al.
ESMO Open
|
June 25, 2020
The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology
Neil Webb, Julie Fricke, Elizabeth Hancock, et al.
Heart (British Cardiac Society)
|
December 23, 2017
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
John J V McMurray, David Trueman, Elizabeth Hancock, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Schizophrenia Bulletin
|
May 8, 2007
A UK audit of screening for the metabolic side effects of antipsychotics in community patients
Thomas R E Barnes, Carol Paton, Mary-Rose Cavanagh, et al.
Manual Therapy
|
June 26, 2012
Low back pain: an assessment using positional MRI and MDT
Karen Hedberg, Lyndsay A Alexander, Kay Cooper, et al.
Advances in Therapy
|
February 9, 2020
An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
Daniel Viriato, Natalie Bennett, Raisa Sidhu, et al.
Advances in Therapy
|
September 24, 2024
A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel versus Tisagenlecleucel in the Treatment of Diffuse Large B-cell Lymphoma Based on a Real-World French Registry
Markqayne Ray, Jean-Gabriel Castaigne, Alexandra Zang, et al.
Swiss Medical Weekly
|
November 30, 2017
Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction
Zanfina Ademi, Alena M Pfeil, Elizabeth Hancock, et al.
Addiction (Abingdon, England)
|
October 22, 2019
Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation
Elizabeth Hancock, Zoe Ward, Rachel Ayres, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
March 3, 2016
Patient experience of negative effects of psychological treatment: results of a national survey†
Mike J Crawford, Lavanya Thana, Lorna Farquharson, et al.
ESMO Open
|
June 25, 2020
The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology
Neil Webb, Julie Fricke, Elizabeth Hancock, et al.
Heart (British Cardiac Society)
|
December 23, 2017
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
John J V McMurray, David Trueman, Elizabeth Hancock, et al.
Page
of 2